Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.82
0.00 (0.00%)
At close: Aug 20, 2025, 9:46 AM
Day One Biopharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -5.52 | -5.66 | -4.51 | 9.09 | -67.12 | -5.61 | -5.84 | -5.71 | -4.88 | -6.8 | -11.35 | -10.46 | -7.44 | -5.22 | -2.18 | -19.1 | -24.68 | -23.96 |
PEG Ratio | 0.32 | 0.11 | 0.02 | -0.01 | 0.72 | -0.35 | -0.39 | 0.50 | -0.2 | -1.6 | 5.45 | 0.52 | -0.3 | 0.07 | -0.00 | -0.55 | 3.09 | 0.43 |
PS Ratio | 19.76 | 26.48 | 40.61 | 14.36 | 144.42 | n/a | 2.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.45 | 1.70 | 2.36 | 2.42 | 3.86 | 4.72 | 3.67 | -2.61 | 2.10 | -3.08 | 4.76 | 3.92 | 2.78 | 2.23 | -8.19 | 4.94 | 4.52 | -21.14 |
P/FCF Ratio | -31.44 | -12.97 | -37.74 | -270.76 | -17.86 | -28.17 | -30.78 | -26.3 | -21.02 | -37 | -44.77 | -61.26 | -36.5 | -26.84 | -201.95 | -120.25 | -105.19 | -82.02 |
P/OCF Ratio | -27.01 | -13.81 | -39.53 | 26.52 | -24.08 | -28.17 | -30.78 | -28.45 | -21.09 | -37.03 | -44.77 | -61.27 | -36.51 | -26.86 | -79.27 | -120.25 | -105.19 | -149.37 |
OCF/S Ratio | -0.73 | -1.92 | -1.03 | 0.54 | -6 | n/a | -73.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | -0.01 |
Quick Ratio | 9.53 | 10.55 | 7.61 | 14.55 | 4.09 | 10.93 | 12.72 | 16.57 | 18.35 | 14.11 | 20.94 | 20.83 | 31.45 | 32.70 | 33.43 | 50.17 | 67.79 | 51.78 |
Current Ratio | 9.65 | 10.62 | 7.66 | 14.62 | 4.09 | 10.93 | 12.72 | 16.57 | 18.35 | 14.11 | 20.94 | 20.83 | 31.45 | 32.70 | 33.43 | 50.17 | 67.79 | 51.78 |
Asset Turnover | 0.07 | 0.06 | 0.05 | 0.16 | 0.02 | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.07 | n/a | n/a | -13.87K | -30.48K | -3.21K | -2.21K | -2.3K |
Return on Equity | -0.07 | -0.08 | -0.13 | 0.07 | -0.01 | -0.21 | -0.16 | 0.11 | -0.11 | 0.11 | -0.1 | -0.09 | -0.09 | -0.11 | 0.94 | -0.06 | -0.05 | 0.22 |
Return on Assets | -0.06 | -0.07 | -0.11 | 0.06 | -0.01 | -0.19 | -0.14 | -0.11 | -0.1 | -0.11 | -0.1 | -0.09 | -0.09 | -0.1 | -0.41 | -0.06 | -0.05 | -0.09 |
Return on Invested Capital | -0.07 | -0.08 | -0.14 | 0.05 | -0.58 | -0.22 | -0.17 | -0.13 | -0.12 | -0.13 | -0.11 | -0.1 | -0.09 | -0.11 | -0.43 | -0.06 | -0.05 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.89 | 0.91 | 0.90 | 0.98 | 0.91 | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -0.89 | -1.17 | -2.25 | 0.40 | -0.54 | n/a | -97.34 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -0.89 | -1.17 | -2.03 | 0.39 | -0.35 | n/a | -97.34 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.03 | -1.34 | -2.24 | 0.32 | -14.01 | n/a | -106.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.03 | -1.31 | -2.21 | 0.32 | -13.98 | n/a | -106.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |